Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M451Revenue (TTM) $M168Net Margin (%)-20.6Altman Z-Score0.7
Enterprise Value $M419EPS (TTM) $-0.5Operating Margin %-15.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-20.5Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio2.8Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %--Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow30.2y-y EBITDA Growth Rate %8.9ROA % (ttm)-7.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-15.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.2ROIC % (ttm)-13.9Gross Margin Increase y-yN

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 6.52-43%Sold Out0
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 6.52-53%New holding19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-43.3view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-46.78view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-42.91view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-42.25view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-44.03view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-40.46view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-41.21view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-47.84view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-44.75view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-45.67view

Quarterly/Annual Reports about SPPI:

News about SPPI:

Articles On GuruFocus.com
AT&T Will Benefit From DirecTV Acquistion Aug 14 2015 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 20, 2016 Jul 20 2016
Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Jul 13 2016
Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Jul 13 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 13 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 6, 2016 Jul 06 2016
Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald's 2nd Annual... Jul 06 2016
Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald’s 2nd Annual... Jul 06 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 01 2016
Forget Valeant, Invest in These Attractive Drug Stocks Instead Jun 28 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : June 21, 2016 Jun 21 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jun 09 2016
Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of... Jun 09 2016
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on... Jun 01 2016
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on... Jun 01 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events May 31 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events May 25 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : May 19, 2016 May 18 2016
Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
SPECTRUM PHARMACEUTICALS INC Financials May 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)